Literature DB >> 31828567

Interactions between Sclerostin and Glycosaminoglycans.

Fuming Zhang1, Jing Zhao2, Xinyue Liu2, Robert J Linhardt3,4,5.   

Abstract

Sclerostin (SOST) is a glycoprotein having many important functions in the regulation of bone formation as a key negative regulator of Wnt signaling in bone. Surface plasmon resonance (SPR), which allows for a direct quantitative analysis of the label-free molecular interactions in real-time, has been widely used for the biophysical characterization of glycosaminoglycan (GAG)-protein interactions. In the present study, we report kinetics, structural analysis and the effects of physiological conditions (e.g., salt concentrations, Ca2+ and Zn2+concentrations) on the interactions between GAGs and recombinant human (rh) and recombinant mouse (rm) SOST using SPR. SPR results revealed that both SOSTs bind heparin with high affinity (rhSOST-heparin, KD~36 nM and rmSOST-heparin, KD~77 nM) and the shortest oligosaccharide of heparin that effectively competes with full size heparin for SOST binding is octadecasaccharide (18mer). This heparin binding protein also interacts with other highly sulfated GAGs including, disulfated-dermatan sulfate and chondroitin sulfate E. In addition, liquid chromatography-mass spectrometry was used to characterize the structure of sulfated GAGs that bound to SOST.

Entities:  

Keywords:  Glycosaminoglycans; Heparin; Interaction; Sclerostin; Surface plasmon resonance

Mesh:

Substances:

Year:  2019        PMID: 31828567     DOI: 10.1007/s10719-019-09900-3

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  30 in total

1.  Characterization of the structural features and interactions of sclerostin: molecular insight into a key regulator of Wnt-mediated bone formation.

Authors:  Vaclav Veverka; Alistair J Henry; Patrick M Slocombe; Andrew Ventom; Barbara Mulloy; Frederick W Muskett; Mariusz Muzylak; Kevin Greenslade; Adrian Moore; Li Zhang; Jianhua Gong; Xueming Qian; Chris Paszty; Richard J Taylor; Martyn K Robinson; Mark D Carr
Journal:  J Biol Chem       Date:  2009-02-10       Impact factor: 5.157

2.  Altered interaction and distribution of glycosaminoglycans and growth factors in mucopolysaccharidosis type I bone disease.

Authors:  Sandra D K Kingma; Tom Wagemans; Lodewijk IJlst; Antonius L J J Bronckers; Toin H van Kuppevelt; Vincent Everts; Frits A Wijburg; Naomi van Vlies
Journal:  Bone       Date:  2016-04-19       Impact factor: 4.398

3.  Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling.

Authors:  Xiaofeng Li; Yazhou Zhang; Heeseog Kang; Wenzhong Liu; Peng Liu; Jianghong Zhang; Stephen E Harris; Dianqing Wu
Journal:  J Biol Chem       Date:  2005-03-18       Impact factor: 5.157

4.  Compositional analysis of heparin/heparan sulfate interacting with fibroblast growth factor.fibroblast growth factor receptor complexes.

Authors:  Fuming Zhang; Zhenqing Zhang; Xinfu Lin; Andrew Beenken; Anna V Eliseenkova; Moosa Mohammadi; Robert J Linhardt
Journal:  Biochemistry       Date:  2009-09-08       Impact factor: 3.162

5.  Sclerostin antibody stimulates bone regeneration after experimental periodontitis.

Authors:  Andrei D Taut; Qiming Jin; Jong-Hyuk Chung; Pablo Galindo-Moreno; Erica S Yi; James V Sugai; Hua Z Ke; Min Liu; William V Giannobile
Journal:  J Bone Miner Res       Date:  2013-11       Impact factor: 6.741

6.  Sulfated hyaluronan improves bone regeneration of diabetic rats by binding sclerostin and enhancing osteoblast function.

Authors:  Ann-Kristin Picke; Juliane Salbach-Hirsch; Vera Hintze; Sandra Rother; Martina Rauner; Christian Kascholke; Stephanie Möller; Ricardo Bernhardt; Stefan Rammelt; M Teresa Pisabarro; Gloria Ruiz-Gómez; Matthias Schnabelrauch; Michaela Schulz-Siegmund; Michael C Hacker; Dieter Scharnweber; Christine Hofbauer; Lorenz C Hofbauer
Journal:  Biomaterials       Date:  2016-04-21       Impact factor: 12.479

7.  Examination of the substrate specificity of heparin and heparan sulfate lyases.

Authors:  R J Linhardt; J E Turnbull; H M Wang; D Loganathan; J T Gallagher
Journal:  Biochemistry       Date:  1990-03-13       Impact factor: 3.162

8.  Selective binding of zinc ions to heparin rather than to other glycosaminoglycans.

Authors:  R F Parrish; W R Fair
Journal:  Biochem J       Date:  1981-02-01       Impact factor: 3.857

9.  Sclerostin inhibition of Wnt-3a-induced C3H10T1/2 cell differentiation is indirect and mediated by bone morphogenetic proteins.

Authors:  David G Winkler; May S Kung Sutherland; Ethan Ojala; Eileen Turcott; James C Geoghegan; Diana Shpektor; John E Skonier; Changpu Yu; John A Latham
Journal:  J Biol Chem       Date:  2004-11-12       Impact factor: 5.157

10.  SPR Biosensor Probing the Interactions between TIMP-3 and Heparin/GAGs.

Authors:  Fuming Zhang; Kyung Bok Lee; Robert J Linhardt
Journal:  Biosensors (Basel)       Date:  2015-07-23
View more
  1 in total

Review 1.  Sclerostin: From Molecule to Clinical Biomarker.

Authors:  Ahmed Omran; Diana Atanasova; Filip Landgren; Per Magnusson
Journal:  Int J Mol Sci       Date:  2022-04-26       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.